CoChat
Sign Up
Cited by 88Genetic Associations and EpidemiologyTGF-β signaling in diseasesBRCA gene mutations in cancer

TGFBR1*6A and Cancer: A Meta-Analysis of 12 Case-Control Studies

Pasche, Boris, Kaklamani, Virginia, Hou, Nanjiang, Young, Taya, Rademaker, Alfred, Peterlongo, Paolo, Ellis, Nathan, Offit, Kenneth +3 more·2004·Journal of Clinical Oncology
DOI 10.1200/jco.2004.99.271
Open this paper in CoChat — free account

Integrity signals

Registry

Crossref · 10.1200/jco.2004.99.271

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • GWAS studies revealed genetic associations between germline variants in genes encoding TGF-β signaling molecules and susceptibilities to cancer and autoimmune disorders.

    “GWAS studies revealed genetic associations between germline variants in genes encoding TGF-β signaling molecules and susceptibilities to cancer and autoimmune disorders396,397”

    From TGFβ biology in cancer progression and immunotherapy (2021) · cites this paper as [397]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Related

Authors
Pasche, B., Kaklamani, V., Hou, N., Young, T., Rademaker, A., Peterlongo, P., Ellis, N., Offit, K., Caldes, T., Reiss, M., & Zheng, T.
Affiliations
  • Northwestern University (US)
  • Memorial Sloan Kettering Cancer Center (US)
  • Hospital Clínico San Carlos, Martin Lagos, Madrid, Spain
  • Robert Wood Johnson Medical School, New Brunswick, NJ
  • Yale University (US)
ORCID
Venue
Journal of Clinical Oncology
Publisher
American Society of Clinical Oncology (ASCO)
Published
2004-02-15
Volume
22
Issue
4
Pages
756-758
ISSN
  • 0732-183X (ISSN-L)
  • 1527-7755
DOI
10.1200/jco.2004.99.271
OpenAlex
W2152601253
Cited by
88
References
1
Citations by year
2022: 1 · 2021: 2 · 2020: 2 · 2019: 1 · 2018: 1 · 2016: 1 · 2015: 4 · 2014: 5 · 2013: 3 · 2012: 4
FWCI
1.56
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Clinical Oncology (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Avon Foundation for Women
  • National Cancer Institute (CA89018, CA90386, P50CA089018, P50CA090386)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › BRCA gene mutations in cancer
Keywords
TGFBR1, TGF-beta type I receptor, genetic polymorphism, cancer susceptibility, case-control study
MeSH terms
Receptor, Transforming Growth Factor-beta Type I, Female, Gene Frequency, Humans, Neoplasms, Protein Serine-Threonine Kinases, Molecular Epidemiology, Receptors, Transforming Growth Factor beta, Genetic Predisposition to Disease, Activin Receptors, Type I

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review